Door Opened On Revising Labeling For Teens, But FDA Not Anxious To Enter
This article was originally published in The Tan Sheet
Executive Summary
FDA executives and researchers are recommending the agency and the drug industry improve drug labels so younger consumers can understand how to safely and effectively use the products. However, some experts say revised labels will not stop adolescents who want to abuse OTC drugs
You may also be interested in...
Drug Industry Must Consider Teens’ “Risk-Taking” Nature – Researcher
Limits on adolescents' access to potentially harmful products because of the high-risk behaviors associated with the age group should be considered, according to psychology researcher Laurence Steinberg, who will speak at FDA's public workshop on adolescents' decision making skills and their use of over-the-counter drug products
FDA Delves Into Unexplored Issue: Adolescent Use Of OTC Drugs
FDA has scheduled a public workshop to gather information on how adolescents use over-the-counter drugs, an area of consumer behavior research largely unexplored, the agency says in a notice prepared for the Nov. 5 Federal Register
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC